Sa Nestle serves as Executive at Seres Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sa Nestle has executed 6 insider transactions totaling $200.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 22, 2020 involved transacting 525,634 shares valued at $84.7M.
Sa Nestle currently holds 525,634 shares of Seres Therapeutics, Inc. (MCRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sa Nestle has been a net buyer of MCRB stock. They have purchased $200.0M and sold $0 worth of shares.
Sa Nestle's most recent insider trade was on Apr 22, 2020, when they sold 525,634 shares at $161.10 per share.
Get notified when new Form 4 filings are submitted
| $16.11 |
| Discretionary |
| Feb 7, 2020 | AIMT | $168.0M | Purchase | 525,634 | $319.68 | Discretionary |
| Feb 7, 2020 | AIMT | $32.0M | Purchase | 1,000,000 | $31.97 | Discretionary |
| Jul 1, 2015 | MCRB | $24.0M | Award | 1,333,333 | $18.00 | Discretionary |
| Jun 26, 2015 | MCRB | $0 | Conversion | 3,611,111 | $N/A | Discretionary |